Eurand, Inc. v. Mylan Pharmaceuticals Inc.
This text of 424 F. App'x 952 (Eurand, Inc. v. Mylan Pharmaceuticals Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
ORDER
ON MOTION
Mylan Pharmaceuticals Inc. et al. submit a motion for a stay, pending appeal, of the injunction entered by the United States District Court for the District of Delaware on May 24, 2011. Mylan also requests an immediate stay of the injunction pending disposition of its motion for a stay, pending appeal and for expedited briefing of the stay motion.
Upon consideration thereof,
It Is Ordered That:
(1) Eurand, Inc. et al. are directed to respond no later, than 12:00 p.m. on May 31, 2011.
(2) Mylan’s request for an immediate stay is granted to the extent that the injunction is temporarily stayed pending the court’s receipt of the response and the court’s consideration of the papers submitted.
Free access — add to your briefcase to read the full text and ask questions with AI
Cite This Page — Counsel Stack
424 F. App'x 952, Counsel Stack Legal Research, https://law.counselstack.com/opinion/eurand-inc-v-mylan-pharmaceuticals-inc-cafc-2011.